Galmed Pharmaceuticals (GLMD)
(Delayed Data from NSDQ)
$1.45 USD
-0.15 (-9.38%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $1.44 -0.01 (-0.69%) 6:20 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Market Cap
As of the previous market close, Galmed Pharmaceuticals Ltd. has a market cap of $2.65M, which represents its share price of $1.60 multiplied by its outstanding shares number of 1.65M. As a small-cap company, GLMD's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
GLMD 1.45 -0.15(-9.38%)
Will GLMD be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for GLMD based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for GLMD
12 Health Care Stocks Moving In Friday's Pre-Market Session
Galmed Pharmaceuticals Unveils Biomarker Signature for Aramchol, Expanding Market Potential
Galmed Identifies Proprietary Biomarker Signature for Aramchol, Unlocking Multi-Billion-Dollar ...
Galmed Pharmaceuticals Reports Q1 2025 Financial Results and Advances in Oncology
Galmed Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business ...